ACADIA Pharmaceuticals Inc. (ACAD) Jumps 7.72% on January 22

Equities Staff |

ACADIA Pharmaceuticals Inc. (ACAD) was among the biggest gainers on the Russell 2000 for Friday January 22 as the stock popped 7.72% to $24.41, representing a gain of $1.75 per share. Some 2.44 million shares traded hands on 14,694 trades, compared with an average daily volume of 1.44 million shares out of a total float of 100.91 million. The stock opened at $24.10 and traded with an intraday range of $25.08 to $23.96.

After today's gains, ACADIA Pharmaceuticals Inc. reached a market cap of $2.46 billion. ACADIA Pharmaceuticals Inc. has had a trading range between $51.99 and $20.42 over the last year, and it had a 50-day SMA of $33.28 and a 200-day SMA of $37.89.

ACADIA Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the business of development and commercialization of small molecule drugs for the treatment of central nervous system disorders.

ACADIA Pharmaceuticals Inc. is based out of San Diego, CA and has some 151 employees. Its CEO is Stephen R. Davis.

For a complete fundamental analysis analysis of ACADIA Pharmaceuticals Inc., check out Equities.com’s Stock Valuation Analysis report for ACAD. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

CMX Gold & Silver Corp.

CMX Gold & Silver Corp is an exploration stage company. The Company is engaged in the acquisition, exploration and development of silver and copper/gold properties in the USA.

Private Markets

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…

Cloudera

Cloudera offers enterprises a new data platform built on the Apache Hadoop open-source software package. Hadoop is a data-management platform that can consolidate data in a single repository for comprehensive…